Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' FINKE J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 147 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Engelhardt, M; Bertz, H; Wasch, R; Finke, J
      Analysis of stem cell apheresis products using intermediate-dose filgrastim plus large volume apheresis for allogeneic transplantation

      ANNALS OF HEMATOLOGY
    2. Korfel, A; Finke, J; Schmidt-Wolf, I; Thiel, E
      5. Report on workshop: Primary CNS lymphoma

      ANNALS OF HEMATOLOGY
    3. Tate, J; Olencki, T; Finke, J; Kottke-Marchant, K; Rybicki, LA; Bukowski, RM
      Phase I trial of simultaneously administered GM-CSF and IL-6 in patients with renal-cell carcinoma: Clinical and laboratory effects

      ANNALS OF ONCOLOGY
    4. Juturi, J; Bukowski, RA; Bocock, K; Bloom, T; Finke, J; Hussein, MA
      High, intermittent dose of all-trans retinoic acid in combination with alpha-interferon for advanced multiple myeloma

      HAEMATOLOGICA
    5. Olencki, T; Peereboom, D; Wood, L; Budd, GT; Novick, A; Finke, J; McLain, D; Elson, P; Bukowski, RM
      Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    6. Hussein, MA; Sandstrom, K; Elson, P; Finke, J; McLain, D; Rayman, P; Rybicki, LA; Bukowski, RA
      GM-CSF safety and effects in the management of advanced/refractory multiple myeloma patients: a phase I trial

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    7. Zenz, T; Rossle, M; Bertz, H; Siegerstetter, V; Ochs, A; Finke, J
      Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation - role of transjugular intrahepatic portosystemic shunt (TIPS)

      LIVER
    8. Teusch, L; Bohme, H; Finke, J; Gastpar, M
      Effects of client-centered psychotherapy for personality disorders alone and in combination with psychopharmacological treatment - An empirical follow-up study

      PSYCHOTHERAPY AND PSYCHOSOMATICS
    9. Teusch, L; Bohme, H; Finke, J
      Exclusive, conflict-centered treatment or integration: different mechanisms of change in panic and agoraphobia by client-centered therapy alone and in combination with behavioral exposure

      NERVENARZT
    10. Buchmann, I; Reinhardt, M; Elsner, K; Bunjes, D; Altehoefer, C; Finke, J; Moser, E; Glatting, G; Kotzerke, J; Guhlmann, CA; Schirrmeister, H; Reske, SN
      2-(Fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma - A bicenter trial

      CANCER
    11. Engelhardt, M; Finke, J
      Does telomere shortening count?

      BLOOD
    12. Binks, M; Passweg, JR; Furst, D; McSweeney, P; Sullivan, K; Besenthal, C; Finke, J; Peter, HH; van Laar, J; Breedveld, FC; Fibbe, VE; Farge, D; Gluckman, E; Locatelli, F; Martini, A; van den Hoogen, F; van de Putte, L; Schattenberg, AVN; Arnold, R; Bacon, PA; Emery, P; Espigado, I; Hertenstein, B; Hiepe, F; Kashyap, A; Kotter, I; Marmont, A; Martinez, A; Pascual, MJ; Gratwohl, A; Prentice, HG; Black, C; Tyndall, A
      Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease

      ANNALS OF THE RHEUMATIC DISEASES
    13. Stockschlader, M; Exner, S; Schmah, O; Finke, J
      Expansion and fibronectin-enhanced retroviral transduction of primary human T lymphocytes for adoptive immunotherapy

      ACUTE LEUKEMIAS VIII: PROGNOSTIC FACTORS AND TREATMENT STRATEGIES
    14. Olencki, T; Finke, J; Tubbs, R; Elson, P; McLain, D; Herzog, P; Budd, GT; Gunn, H; Bukowski, RM
      Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: Clinical and biologic effects

      JOURNAL OF IMMUNOTHERAPY
    15. Teusch, L; Finke, J; Luderer, HJ; Speierer, GW
      Methodological openness as a basis for integrative psychotherapy

      PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE
    16. Veelken, H; Wasch, R; Behringer, D; Bertz, H; Finke, J
      Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning

      BONE MARROW TRANSPLANTATION
    17. Wasch, R; Reisser, S; Hahn, J; Bertz, H; Engelhardt, M; Kunzmann, R; Veelken, H; Holler, E; Finke, J
      Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan andallogeneic transplantation

      BONE MARROW TRANSPLANTATION
    18. Finke, J; Bertz, H; Schmoor, C; Veelken, H; Behringer, D; Wasch, R; Kunzmann, R; Heidecker, L; Lang, H; Meyer-Konig, U; Mertelsmann, R
      Allogeneic bone marrow transplantation from unrelated donors using in vivoanti-T-cell globulin

      BRITISH JOURNAL OF HAEMATOLOGY
    19. Wasch, R; Bertz, H; Kunzmann, R; Finke, J
      Incidence of mixed chimaerism and clinical outcome in 101 patients after myeloablative conditioning regimens and allogeneic stem cell transplantation

      BRITISH JOURNAL OF HAEMATOLOGY
    20. Stockschlader, M; Haiss, M; Exner, S; Schmah, O; Veelken, H; Follo, M; Ruger, R; Finke, J
      Expansion and fibronectin-enhanced retroviral transduction of primary human T lymphocytes for adoptive immunotherapy

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    21. Bukowski, RM; Rayman, P; Molto, L; Tannenbaum, CS; Olencki, T; Peereboom, D; Tubbs, R; McLain, D; Budd, GT; Griffin, T; Novick, A; Hamilton, TA; Finke, J
      Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma

      CLINICAL CANCER RESEARCH
    22. Finke, J; Teusch, L
      Outlines of a manual-directed client-centered therapy of depressive disorders

      PSYCHOTHERAPEUT
    23. Krause, T; Eisenmann, N; Reinhardt, M; Bathmann, J; Altehoefer, C; Finke, J; Moser, E
      Bone marrow scintigraphy using Technetium-99m antigranulocyte antibody in malignant lymphomas

      ANNALS OF ONCOLOGY
    24. Engelhardt, M; Bertz, H; Afting, M; Waller, CF; Finke, J
      High- versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection

      JOURNAL OF CLINICAL ONCOLOGY
    25. Hoffken, G; Pasold, R; Pfluger, KH; Finke, J; Fauser, AA; Szelenyi, H; Wagner, J
      An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients

      Journal of antimicrobial chemotherapy
    26. Tyndall, A; Fassas, A; Passweg, J; de Elvira, CR; Attal, M; Brooks, P; Black, C; Durez, P; Finke, J; Forman, S; Fouillard, L; Furst, D; Holmes, JA; Joske, D; Jouet, JP; Kotter, I; Locatelli, F; Prentice, HG; Marmont, AM; McSweeney, P; Musso, M; Peter, HH; Snowden, JA; Sullivan, K; Tichelli, A; Vavriec, J; Wulffraat, NM; Schmitz, N; Gratwohl, A
      Autologous haematopoietic stem cell transplants for autoimmune disease - feasibility and transplant-related mortality

      BONE MARROW TRANSPLANTATION
    27. Behringer, D; Bertz, H; Schmoor, C; Berger, C; Dwenger, A; Finke, J
      Quantitative lymphocyte subset reconstitution after allogeneic hematopoietic transplantation from matched related donors with CD34(+) selected PBPC grafts, unselected PBPC grafts or BM grafts

      BONE MARROW TRANSPLANTATION
    28. Bertz, H; Afting, M; Kreisel, W; Duffner, U; Greinwald, R; Finke, J
      Feasibility and response to budesonide as topical corticosteroid therapy for acute intestinal GVHD

      BONE MARROW TRANSPLANTATION
    29. Berger, C; Bertz, H; Schmoor, C; Behringer, D; Potthoff, K; Mertelsmann, R; Finke, J
      Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors

      BONE MARROW TRANSPLANTATION
    30. Finke, J; Ferrone, S; Frey, A; Mufson, A; Ochoa, A
      Where have all the T cells gone? Mechanisms of immune evasion by tumors

      IMMUNOLOGY TODAY
    31. Kolenko, V; Bloom, T; Rayman, P; Bukowski, R; Hsi, E; Finke, J
      Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and-3

      JOURNAL OF IMMUNOLOGY
    32. Hehlmann, R; Hochhaus, A; Kolb, HJ; Hasford, J; Gratwohl, A; Heimpel, H; Siegert, W; Finke, J; Ehninger, G; Holler, E; Berger, U; Pfirrmann, M; Muth, A; Zander, A; Fauser, AA; Heyll, A; Nerl, C; Hossfeld, DK; Loffler, H; Pralle, H; Queisser, W; Tobler, A
      Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure

      BLOOD
    33. Kolenko, V; Rayman, P; Roy, B; Cathcart, MK; O'Shea, J; Tubbs, R; Rybicki, L; Bukowski, R; Finke, J
      Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E-2 and other cyclic adenosine monophosphate-elevating agents: Impact on interleukin-2 receptor signaling pathway

      BLOOD
    34. Hamilton, TA; Tannenbaum, CS; Finke, J; Bukowski, R
      Interactions between chemokines and other cytokines in host response to tumor

      CHEMOKINES AND CANCER
    35. FINKE J
      HERMENEUTIC ASPECTS IN PSYCHOTHERAPY - CL IENT-CENTERED PSYCHOTHERAPY

      Zeitschrift fur klinische Psychologie, Psychiatrie und Psychotherapie
    36. GLIMM H; FLUGGE K; MOBEST D; HOFMANN VM; POSTMUS J; HENSCHLER R; LANGE W; FINKE J; KIEM HP; SCHULZ G; ROSENTHAL F; MERTELSMANN R; VONKALLE C
      EFFICIENT SERUM-FREE RETROVIRAL GENE-TRANSFER INTO PRIMITIVE HUMAN HEMATOPOIETIC PROGENITOR CELLS BY A DEFINED, HIGH-TITER, NONCONCENTRATEDVECTOR-CONTAINING MEDIUM

      Human gene therapy
    37. WEBERNORDT RM; MERTELSMANN R; FINKE J
      THE JAK-STAT PATHWAY - SIGNAL-TRANSDUCTION INVOLVED IN PROLIFERATION,DIFFERENTIATION AND TRANSFORMATION

      Leukemia & lymphoma
    38. KERN W; BRAESS J; BERTZ H; POTT C; SCHLEYER E; FINKE J; RUCHEL R; HIDDEMANN W
      CHRONIC SYSTEMIC ASPERGILLOSIS IN A PATIENT WITH ACUTE MYELOID-LEUKEMIA

      Annals of hematology
    39. BOHME H; FINKE J; TEUSCH L
      EFFECTS OF INPATIENT CLIENT-CENTERED PSYC HOTHERAPY ON SEVERAL DISORDERS

      PPmP. Psychotherapie, Psychosomatik, medizinische Psychologie
    40. HERRMANN J; GUGEL A; FREIDANK H; BERTZ H; FINKE J
      ASPERGILLUS ANTIGEN-DETECTION - COMPARISON OF A NEW SANDWICH-ELISA WITH THE LATEX AGGLUTINATION-TEST IN PATIENTS WITH HISTOLOGICALLY PROVENINVASIVE ASPERGILLOSIS

      Mycoses
    41. Finke, J; Kobold, U; Dulffer, T; Pongratz, S; Puhlmann, A; Rudolphi, A
      Characterization of ethoxylates by High-Temperature Gas Chromatography andits use in quality control

      TENSIDE SURFACTANTS DETERGENTS
    42. LIU J; FINKE J; KRAUSS JC; SHU SY; PLAUTZ GE
      EX-VIVO ACTIVATION OF TUMOR-DRAINING LYMPH-NODE T-CELLS REVERSES DEFECTS IN SIGNAL-TRANSDUCTION MOLECULES

      Cancer immunology and immunotherapy
    43. SOMMERKAMP H; FINKE J
      CYCLOPHOSPHAMIDE-INDUCED HEMORRHAGIC CYSTITIS - AN INTERDISCIPLINARY PROBLEM

      Der Urologe
    44. FINKE J; BERTZ H; AFTING M; BEHRINGER D; BERGER C; HEIDECKER L; KUNZMANN R; MARKS R; POTTHOFF K; WASCH R; WINKLER J; MERTELSMANN R
      ALLOGENEIC TRANSPLANTATION OF CD34-BLOOD PROGENITOR CELLS( SELECTED OR UNSELECTED PERIPHERAL)

      Bone marrow transplantation
    45. ARNOLD R; BUNJES D; DEEG HJ; EINSELE H; FAUSER AA; FINKE J; HERTENSTEIN B; HEYLL A; KOLB HJ; KOLBE K; MARTIN H; NIEDERWIESER D; SCHAEFER UW; SCHMITZ N; SCHWERDTFEGER R; SIEGERT W; WANDT H; ZANDER A; GOEKBUGET N; HOELZER D
      BMT IN REFRACTORY OR RELAPSED ADULT ALL PATIENTS TREATED IN THE GERMAN MULTICENTER ALL STUDIES

      Bone marrow transplantation
    46. PASSWEG J; FASSAS A; FURST D; BLACK C; FINKE J; JOUET J; LOCATELLI F; MARMONT A; MARTINI A; MERTELSMANN R; MUSSO M; PETER H; PRENTICE H; SULLIVAN K; GRATWOHL A; TYNDALL A
      AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR AUTOIMMUNE-DISEASE - A PRELIMINARY-REPORT

      Bone marrow transplantation
    47. STOCKSCHLADER M; HAISS M; EXNER S; FEHSE B; ZANDER A; RUGER R; KOCH S; METTELSMANN R; FINKE J
      IMPROVED RETROVIRAL TRANSDUCTION OF HUMAN T-CELLS

      Bone marrow transplantation
    48. BERTZ H; EISOLD A; HEIDECKER L; LEIFERT J; MERTELSMANN R; FINKE J
      POSTTRANSPLANT MICROANGIOPATHIC HEMOLYTIC-ANEMIA (MAHA) IS ASSOCIATEDWITH ACUTE GVHD

      Bone marrow transplantation
    49. BERTZ H; SCHMOLK J; KORTSIK P; HEIDECKER L; LEIFERT J; MERTELSMANN R; FINKE J
      SEQUENTIAL PULMONARY-FUNCTION TESTING AFTER ALLOGENEIC TRANSPLANTATION

      Bone marrow transplantation
    50. ENGELHARDT M; WALLER C; BERTZ H; AFTING M; MERTELSMANN R; FINKE J
      HIGH-DOSE VERSUS STANDARD FILGRASTIM SIGNIFICANTLY IMPROVES MOBILIZATION OF BLOOD PROGENITORS AND FACILITATES CD34+ IMMUNOSELECTION FOR ALLOGENEIC TRANSPLANTATION

      Bone marrow transplantation
    51. BERTZ H; LAUBENBERGER J; STEINFURTH G; FINKE J
      SINUS VENOUS THROMBOSIS - AN UNUSUAL CAUSE FOR NEUROLOGIC SYMPTOMS AFTER BONE-MARROW TRANSPLANTATION UNDER IMMUNOSUPPRESSION

      Transplantation
    52. CAMPBELL CE; KURIYAN NP; RACKLEY RR; CAULFIELD MJ; TUBBS R; FINKE J; WILLIAMS BRG
      CONSTITUTIVE EXPRESSION OF THE WILMS-TUMOR SUPPRESSOR GENE (WT1) IN RENAL-CELL CARCINOMA

      International journal of cancer
    53. BERTZ H; KUNZMAN R; BUNJES D; FINKE J
      SUCCESSFUL ADOPTIVE IMMUNOTHERAPY FOR RELAPSE OF AML 9 YEARS AFTER T-CELL-DEPLETED EMT

      British Journal of Haematology
    54. LING WJ; RAYMAN P; UZZO R; CLARK P; KIM HJ; TUBBS R; NOVICK A; BUKOWSKI R; HAMILTON T; FINKE J
      IMPAIRED ACTIVATION OF NF-KAPPA-B IN T-CELLS FROM A SUBSET OF RENAL-CELL CARCINOMA PATIENTS IS MEDIATED BY INHIBITION OF PHOSPHORYLATION AND DEGRADATION OF THE INHIBITOR, I-KAPPA-B-ALPHA

      Blood
    55. FINKE J; ROY M; JENNINGS PA
      A SURFACE LOOP MUTATION AFFECTS EARLY EVENTS IN THE FOLDING OF INTERLEUKIN-1B

      Biophysical journal
    56. FETSCHER S; FINKE J; ENGELHARDT R; MERTELSMANN R; LANGE W
      HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN PATIENTS WITH 2ND PRIMARY MALIGNANCIES

      HEMATOLOGY AND CELL THERAPY
    57. BUKOWSKI RM; OLENCKI T; WANG Q; PEEREBOOM D; BUDD GT; ELSON P; SANDSTROM K; TUASON L; RAYMAN P; TUBBS R; MCLAIN D; KLEIN E; NOVICK A; FINKE J
      PHASE-II TRIAL OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN PATIENTS WITHRENAL-CELL CARCINOMA - CLINICAL-RESULTS AND IMMUNOLOGICAL CORRELATES OF RESPONSE

      Journal of immunotherapy with emphasis on tumor immunology
    58. FETSCHER S; FINKE J; ENGELHARDT R; MERTELSMANN R; LANGE W
      EARLY-ONSET SECONDARY MALIGNANCIES AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION

      Annals of hematology
    59. BERTZ H; BURGER JA; KUNZMANN R; MERTELSMANN R; FINKE J
      ADOPTIVE IMMUNOTHERAPY FOR RELAPSED MULTIPLE-MYELOMA AFTER ALLOGENEICBONE-MARROW TRANSPLANTATION (BMT) - EVIDENCE FOR A GRAFT-VERSUS-MYELOMA EFFECT

      Leukemia
    60. TANNENBAUM CS; TUBBS R; ARMSTRONG D; FINKE J; BUKOWSKI R; HAMILTON T
      ANTITUMOR FUNCTIONS OF IP-10 AND MIG

      Journal of leukocyte biology
    61. OTTINGER HD; ALBERT E; ARNOLD R; BEELEN DW; BLASCZYK R; BUNJES D; BURDACH S; EBELL W; EHNINGER G; EINSELE H; ENCZMANN J; FAUSER A; FRIEDRICH W; FINKE J; GOBEL U; GOLDMANN SF; GRAMATZKI M; HELBIG W; KANZ L; KLINGSBIEL T; KOLB HJ; KUHNL P; LOLIGER C; MULLER CR; MULLER CA; NIETHAMMER D; SCHAEFER UW; SAYER H; SCHMITZ N; SCHULZERATH R; WASSMUTH R; WERNET P; WESTPHAL E; ZANDER R; ZINTL F; GROSSEWILDE H
      GERMAN CONSENSUS ON IMMUNOGENETIC DONOR SEARCH FOR TRANSPLANTATION OFALLOGENEIC BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELLS

      Bone marrow transplantation
    62. FETSCHER S; LUBBERT M; KANZ L; BEHRINGER D; FINKE J; MERTELSMANN R; LANGE W
      TREATMENT OF RELAPSED NON-HODGKINS-LYMPHOMA AFTER BEAM CHEMOTHERAPY AND AUTOLOGOUS TRANSPLANTATION BY BU CY CHEMOTHERAPY AND SALVAGE TRANSPLANTATION/

      Bone marrow transplantation
    63. BERTZ H; POTTHOFF K; MERTELSMANN R; FINKE J
      BUSULFAN CYCLOPHOSPHAMIDE IN VOLUNTEER UNRELATED DONOR (VUD) BMT - EXCELLENT FEASIBILITY AND LOW INCIDENCE OF TREATMENT-RELATED TOXICITY/

      Bone marrow transplantation
    64. TYNDALL A; BLACK C; FINKE J; WINKLER J; MERTLESMANN R; PETER HH; GRATWOHL A
      TREATMENT OF SYSTEMIC-SCLEROSIS WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION

      Lancet
    65. FISCHER A; LUDEMANN M; SCHULTEMONTING J; FINKE J; IMDAHL A; FARTHMANN EH
      THERAPEUTIC RESULTS IN PATIENTS WITH SOFT -TISSUE SARCOMA - A RETROSPECTIVE STUDY TO IDENTIFY INDEPENDENT PROGNOSTIC VARIABLES

      Zentralblatt fur Chirurgie
    66. FINKE J; EDWARDS B
      TEACHER-EDUCATION STUDENTS INSIGHTS FROM INTERGENERATIONAL LITERATURECIRCLES

      Journal of teacher education
    67. KOLENKO V; WANG Q; RIEDY MC; OSHEA J; RITZ J; CATHCART MK; RAYMAN P; TUBBS R; EDINGER M; NOVICK A; BUKOWSKI R; FINKE J
      TUMOR-INDUCED SUPPRESSION OF T-LYMPHOCYTE PROLIFERATION COINCIDES WITH INHIBITION OF JAK3 EXPRESSION AND IL-2 RECEPTOR SIGNALING - ROLE OF SOLUBLE PRODUCTS FROM HUMAN RENAL-CELL CARCINOMAS

      The Journal of immunology
    68. KORNER I; WEBERNORDT R; PFAFF P; FINKE J
      ANALYSIS OF A REGULATORY ELEMENT IN THE 5'-UNTRANSLATED REGION OF THEBCL-2 GENE

      FEBS letters
    69. WEBERNORDT R; SCHRIEVER T; FINKE J
      IN-VITRO EXPANSION - MORPHOLOGICAL AND FUNCTIONAL ANALYSES OF CORD-BLOOD DERIVED HEMATOPOIETIC PROGENITOR CELLS

      Blood
    70. HUSSEIN MA; SNYDER J; FINKE J; RAYMAN P; MCLAIN D; ELSON P; BUKOWSKI RM
      THE EFFECT OF IL-2 MAINTENANCE (MN) THERAPY (TX) ON THE DURATION OF THE PLATEAU-PHASE IN RESPONDING MULTIPLE-MYELOMA (MM) PATIENTS (PTS)

      Blood
    71. HUSSEIN MA; ZUCCARO K; BLOOM T; FINKE J; ELSON P; BUKOWSKI RM
      HIGH-DOSE ALL-TRANS-RETINOIC ACID (ATRA) IN MULTIPLE-MYELOMA (MM)

      Blood
    72. FINKE J; MOLTO L; BLOOM T; KOLENKO V; POHLMAN B; LICHTIN A; MCLAIN D; TUBBS R; BUKOWSKI RM
      CD40L IS NOT EXPRESSED ON T-CELLS INFILTRATING NON-HODGKINS-LYMPHOMA B-CELLS AND IS POORLY INDUCED AFTER STIMULATION

      Blood
    73. FINKE J; BERTZ H; KUNZMANN R; BEHRINGER D; AFTING M; HEIDECKER E; LANG H; POTTHOFF K; WASCH R; MERTELSMANN R
      ALLOGENEIC TRANSPLANTATION FROM UNRELATED DONORS - IMPROVED OUTCOME USING IN-VIVO T-CELL DEPLETION

      Blood
    74. PASSWEG JR; FASSAS A; BLACK CM; FINKE J; JOUET JP; LOCATELLI F; MARMONT A; MARTINI A; MERTELSMANN R; PETER HH; PRENTICE HG; GRATWOHL A; TYNDALL A
      AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR AUTOIMMUNE-DISEASE - A PRELIMINARY-REPORT

      Blood
    75. FETSCHER S; TECHNAU K; MERTENS R; FINKE J; MERTELSMANN R; LANGE W
      INCIDENCE AND MORBIDITY OF HERPES-ZOSTER INFECTION AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION

      Blood
    76. FINKE J; BLOOM T; RAYMAN P; SNYDER J; MCLAIN D; BUKOWSKI RM; HUSSEIN MA
      ACTIVATION OF THE TRANSCRIPTION FACTOR NF-KAPPA-B IN PERIPHERAL-BLOODT-CELLS FROM MULTIPLE-MYELOMA PATIENTS IS IMPAIRED AND MAY CONTRIBUTETO THEIR INCREASED SUSCEPTIBILITY TO ACTIVATION-INDUCED APOPTOSIS

      Blood
    77. STOCKSCHLADER M; HAISS M; EXNER S; FEHSE B; SCHADE U; ZANDER A; RUGER R; KOCH S; ROSENTHAL F; VONKALLE C; MERTELSMANN R; FINKE J
      FIBRONECTIN ENHANCES RETROVIRAL TRANSDUCTION OF PRIMARY HUMAN T-LYMPHOCYTES

      Blood
    78. ROTH A; PFAFF P; LANGE W; FINKE J
      INFLUENCE OF EPSTEIN-BARR-VIRUS LATENT GENE-EXPRESSION ON THE APOPTOSIS-INDUCING EFFECTS OF CORTISONE AND 2-CHLORODEOXYADENOSINE (2-CDA) INB-CELL LINES

      Cytokines and molecular therapy
    79. BUKOWSKI RM; OLENCKI T; GUNN H; MCLAIN D; BUDD GT; SANDSTROM K; TUASON L; REDOVAN C; RAYMAN P; TUBBS R; RESTA D; ELSON P; FINKE J
      PHASE-I TRIAL OF SUBCUTANEOUS INTERLEUKIN-3 IN PATIENTS WITH REFRACTORY MALIGNANCY - HEMATOLOGICAL, IMMUNOLOGICAL, AND PHARMACODYNAMIC FINDINGS

      Clinical cancer research
    80. OLENCKI T; FINKE J; TUBBS R; TUASON L; GREENE T; MCLAIN D; SWANSON SJ; HERZOG P; STANLEY T; EDINGER M; BUDD GT; BUKOWSKI RM
      IMMUNOMODULATORY EFFECTS OF INTERLEUKIN-2 AND INTERLEUKIN-4 IN PATIENTS WITH MALIGNANCY

      Journal of immunotherapy with emphasis on tumor immunology
    81. WEBERNORDT RM; EGEN C; WEHINGER J; MERTELSMANN R; FINKE J
      CONSTITUTIVE ACTIVATION OF STAT PROTEINS IN PRIMARY HUMAN LEUKEMIA-CELLS

      The FASEB journal
    82. KOLENKO V; BUKOWSKI R; FINKE J
      PROSTAGLANDIN E(2) (PGE(2)) MODULATES THE EXPRESSION OF JAK3 IN NAIVEAND ACTIVATED T-LYMPHOCYTES

      The FASEB journal
    83. FINKE J; RAYMAN P; LI X; LIU J; HAMILTON T; KIM HJ; TUBBS R; NOVICK A; BUKOWSKI R
      SUPPRESSION OF NF-KAPPA-B ACTIVATION IN NORMAL T-CELLS BY SOLUBLE PRODUCTS FROM RENAL-CELL CARCINOMA EXPLANTS

      The FASEB journal
    84. WANG Q; KOLENKO V; RAYMAN P; TUBBS R; NOVICK A; BUKOWSKI R; FINKE J
      SUPPRESSION OF TCR-CD3 LINKED TYROSINE PHOSPHORYLATION OF NORMAL PERIPHERAL-BLOOD T-CELLS BY TUMOR SUPERNATANTS FROM RENAL-CELL CARCINOMA (RCC)

      The FASEB journal
    85. ULCHAKER J; PANUTO J; KOLENKO V; RAYMAN P; NOVICK A; ELSON P; TUBBS R; BUKOWSKI R; FINKE J
      EFFECTS OF INTERLEUKIN-12 ON INTERFERON-GAMMA PRODUCTION BY PERIPHERAL-BLOOD AND TUMOR-INFILTRATING T-LYMPHOCYTES FROM RENAL-CELL CARCINOMAPATIENTS - EVIDENCE OF IMPAIRED SECRETION

      The FASEB journal
    86. WEBERNORDT RM; SCHOTT E; FINKE J; HENSCHLER R; SCHULZ G; MERTELSMANN R
      UMBILICAL-CORD BLOOD - AN ALTERNATIVE TO THE TRANSPLANTATION OF BONE-MARROW STEM-CELLS

      Cancer treatment reviews
    87. FINKE J; BRUGGER W; BERTZ H; BEHRINGER D; KUNZMANN R; WEBERNORDT RM; KANZ L; MERTELSMANN R
      ALLOGENEIC TRANSPLANTATION OF POSITIVELY SELECTED PERIPHERAL-BLOOD CD34(+) PROGENITOR CELLS FROM MATCHED RELATED DONORS

      Bone marrow transplantation
    88. DIMEO F; BERTZ H; FINKE J; FETSCHER S; MERTELSMANN R; KEUL J
      AN AEROBIC EXERCISE PROGRAM FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AFTER BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    89. WALLER CF; BERTZ H; WENGER MK; FETSCHER S; HARDUNG M; ENGELHARDT M; BEHRINGER D; LANGE W; MERTELSMANN R; FINKE J
      MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS FOR ALLOGENEIC TRANSPLANTATION - EFFICACY AND TOXICITY OF A HIGH-DOSE RHG-CSF REGIMEN

      Bone marrow transplantation
    90. SCHMITZ N; BACIGALUPO A; LABOPIN M; MAJOLINO I; LAPORTE JP; BRINCH L; COOK G; LAMBERTENGHIDELILIERS G; LANGE A; ROZMAN C; GARCIACONDE J; FINKE J; DOMINGOALBOS A; GRATWOHL A
      TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR CELLS - THEEBMT EXPERIENCE

      Bone marrow transplantation
    91. ENGELHARDT R; FINKE J; KULMBURG P; LANGE W; LINDEMANN A; MACKENSEN A; MARTELSMANN R; ROSENTHAL F; VEELKEN H
      SOMATIC-CELL AND GENE-THERAPY - PERSPECTIVES IN ONCOLOGY

      Naunyn-Schmiedeberg's archives of pharmacology
    92. TANNENBAUM CS; WICKER N; ARMSTRONG D; TUBBS R; FINKE J; BUKOWSKI RM; HAMILTON TA
      CYTOKINE AND CHEMOKINE EXPRESSION IN TUMORS OF MICE RECEIVING SYSTEMIC THERAPY WITH IL-12

      The Journal of immunology
    93. WEHINGER J; GOUILLEUX F; GRONER B; FINKE J; MERTELSMANN R; WEBERNORDT RM
      IL-10 INDUCES DNA-BINDING ACTIVITY OF 3 STAT PROTEINS (STAT1, STAT3, AND STAT5) AND THEIR DISTINCT COMBINATORIAL ASSEMBLY IN THE PROMOTERS OF SELECTED GENES

      FEBS letters
    94. KURRLEWEITTENHILLER A; HOLZEL W; ENGEL D; FINKE J; KLEIN G
      METHOD FOR THE DETERMINATION OF TOTAL AND PANCREATIC ALPHA-AMYLASE BASED ON 100-PERCENT CLEAVAGE OF THE PROTECTED SUBSTRATE ETHYLIDENE-4-NITROPHENYL-MALTOHEPTAOSIDE

      Clinical chemistry
    95. WOS E; OLENCKI T; TUASON L; BUDD GT; PEEREBOOM D; SANDSTROM K; MCLAIN D; FINKE J; BUKOWSKI RM
      PHASE-II TRIAL OF SUBCUTANEOUSLY ADMINISTERED GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA

      Cancer
    96. SCHMITZ N; BACIGALUPO A; LABOPIN M; MAJOLINO I; LAPORTE JP; BRINCH L; COOK G; DELILIERS GL; LANGE A; ROZMAN C; GARCIACONDE J; FINKE J; DOMINGOALBOS A; GRATWOHL A
      TRANSPLANTATION OF PERIPHERAL-BLOOD PROGENITOR CELLS FROM HLA-IDENTICAL SIBLING DONORS

      British Journal of Haematology
    97. WEBERNORDT RM; HENSCHLER R; SCHOTT E; WEHINGER J; BEHRINGER D; MERTELSMANN R; FINKE J
      INTERLEUKIN-10 INCREASES BCL-2 EXPRESSION AND SURVIVAL IN PRIMARY HUMAN CD34(+) HEMATOPOIETIC PROGENITOR CELLS

      Blood
    98. WEBERNORDT RM; EGEN C; WEHINGER J; LUDWIG W; GOUILLEUXGRUART V; MERTELSMANN R; FINKE J
      CONSTITUTIVE ACTIVATION OF STAT PROTEINS IN PRIMARY LYMPHOID AND MYELOID-LEUKEMIA CELLS AND IN EPSTEIN-BARR-VIRUS (EBV)-RELATED LYMPHOMA CELL-LINES

      Blood
    99. WEBERNORDT RM; LANG S; MERTELSMANN R; FINKE J
      FAS AND FAS LIGAND EXPRESSION IN HUMAN LEUKEMIAS AND LYMPHOMAS

      Blood
    100. WEBERNORDT RM; WEHINGER J; EGEN C; MERTELSMANN R; FINKE J
      INHIBITION OF STAT-PROTEIN PHOSPHORYLATION DECREASES PROLIFERATION INMURINE AND HUMAN LEUKEMIA-CELLS

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/10/20 alle ore 12:57:28